SNY

Sanofi FR
NASDAQ

Real-time Quotes | Nasdaq Last Sale

50.85
+0.10
+0.20%
After Hours: 51.20 +0.35 +0.69% 18:58 02/21 EST
OPEN
50.29
PREV CLOSE
50.75
HIGH
50.88
LOW
50.11
VOLUME
1.72M
TURNOVER
--
52 WEEK HIGH
51.84
52 WEEK LOW
40.00
MARKET CAP
127.13B
P/E (TTM)
39.06
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SNY and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SNY stock price target is 56.88 with a high estimate of 61.00 and a low estimate of 53.00.

EPS

SNY News

More
  • A Plan to Use Blockchain to Stop Counterfeit Drugs Moves Forward
  • MotleyFool.com · 1d ago
  • Oscar Health Cuts Co-Pays on About 100 Drugs to $3
  • MotleyFool.com · 1d ago
  • Investors Scrambled to Buy This Biotech IPO
  • MotleyFool.com · 1d ago
  • Pharma Stock Roundup: AZN Reports Q4 Results, NVS, PFE Drugs Get EU Approval
  • Zacks · 1d ago

Industry

Pharmaceuticals
+0.60%
Pharmaceuticals & Medical Research
+0.54%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About SNY

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company's pharmaceuticals operations. The Vaccines segment is dedicated to vaccines and includes the commercial operations of the Company's vaccines division Sanofi Pasteur and dedicated research and development, production and marketing activities for the Company's vaccines operations. Its Rare Diseases products include Cerezyme, Cerdelga, Myozyme and Lumizyme, Fabrazyme, and Aldurazyme. It partners with Alnylam Pharmaceuticals.
More

Webull offers kinds of Sanofi SA (ADR) stock information, including NASDAQ:SNY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNY stock news, and many more online research tools to help you make informed decisions.